WP
THRD

Woodline Partners’s Third Harmonic Bio THRD Stock Holding History

Woodline Partners’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,692
Closed -$141K – 1044
2025
Q1 		$141K Buy
+40,692
New +$197K ﹤0.01% 884
2024
Q4 		– Sell
-123,923
Closed -$1.68M – 999
2024
Q3 		$1.68M Buy
+123,923
New +$1.54M 0.01% 485
2022
Q4 		– Sell
-200,063
Closed -$3.79M – 845
2022
Q3 		$3.79M Buy
+200,063
New +$3.61M 0.05% 347

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Woodline Partners's THRD Position: Q2 2025 in Review

Woodline Partners sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 40,692 shares — an estimated $141K sold.

Woodline Partners first reported a position in THRD in Q3 2022 and held it in 3 quarters. The position peaked at $3.79M in Q3 2022. 105 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

  • Woodline Partners reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
  • Woodline Partners sold 40,692 Third Harmonic Bio shares in Q2 2025, an estimated $141K.
  • Woodline Partners first reported a position in Third Harmonic Bio in Q3 2022 and held it in 3 quarters.
  • Woodline Partners's Third Harmonic Bio position peaked at $3.79M in Q3 2022.
  • 105 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.